MedPath

To compare the anti-craving effect of three drugs Naltrexone, Topiramate and Baclofen in patients using alcohol.

Phase 4
Conditions
Health Condition 1: F102- Alcohol dependence
Registration Number
CTRI/2019/05/019346
Lead Sponsor
SGT University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

2.Availability of reliable informant

3.Fulfilling ICD-10 diagnostic criteria for alcohol dependence

4.Patient suitable for out-patient treatment

5.Patient consenting to participate in study

Exclusion Criteria

1.Presence of significant medical comorbidity requiring/undergoing treatment (as assessed by through physical examination and routine laboratory screening)

2.Presence of another co existing major psychiatric disorder

3.Presence of another drug abuse except nicotine

4.Hypersensitivity to any of these drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CravingTimepoint: 1 week, 2 week, 3 week, 4 week
Secondary Outcome Measures
NameTimeMethod
cravingTimepoint: 1 month
© Copyright 2025. All Rights Reserved by MedPath